| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |